ATE389021T1 - Rrekombinante proteine eines pakistani-stammes von hepatitis-e-virus, ihre verwendung in diagnotischen verfahren und als impfstoff - Google Patents

Rrekombinante proteine eines pakistani-stammes von hepatitis-e-virus, ihre verwendung in diagnotischen verfahren und als impfstoff

Info

Publication number
ATE389021T1
ATE389021T1 AT98919756T AT98919756T ATE389021T1 AT E389021 T1 ATE389021 T1 AT E389021T1 AT 98919756 T AT98919756 T AT 98919756T AT 98919756 T AT98919756 T AT 98919756T AT E389021 T1 ATE389021 T1 AT E389021T1
Authority
AT
Austria
Prior art keywords
hepatitis
proteins
vaccine
virus
rrecombinant
Prior art date
Application number
AT98919756T
Other languages
English (en)
Inventor
Suzanne Emerson
Robert Purcell
Sergei A Tsarev
Robin Robinson
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE389021T1 publication Critical patent/ATE389021T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/28011—Hepeviridae
    • C12N2770/28111—Hepevirus, e.g. hepatitis E virus
    • C12N2770/28122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98919756T 1997-04-11 1998-04-09 Rrekombinante proteine eines pakistani-stammes von hepatitis-e-virus, ihre verwendung in diagnotischen verfahren und als impfstoff ATE389021T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/840,316 US6054567A (en) 1997-04-11 1997-04-11 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

Publications (1)

Publication Number Publication Date
ATE389021T1 true ATE389021T1 (de) 2008-03-15

Family

ID=25282015

Family Applications (2)

Application Number Title Priority Date Filing Date
AT98919756T ATE389021T1 (de) 1997-04-11 1998-04-09 Rrekombinante proteine eines pakistani-stammes von hepatitis-e-virus, ihre verwendung in diagnotischen verfahren und als impfstoff
AT08004467T ATE530563T1 (de) 1997-04-11 1998-04-09 Rekombinante proteine einer pakistanischen hepatitis e variante und ihre verwendung in diagnoseverfahren und impfungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT08004467T ATE530563T1 (de) 1997-04-11 1998-04-09 Rekombinante proteine einer pakistanischen hepatitis e variante und ihre verwendung in diagnoseverfahren und impfungen

Country Status (10)

Country Link
US (1) US6054567A (de)
EP (2) EP0972048B1 (de)
JP (1) JP4390293B2 (de)
CN (1) CN1202252C (de)
AT (2) ATE389021T1 (de)
AU (1) AU739915B2 (de)
CA (1) CA2286399C (de)
DE (1) DE69839242T2 (de)
ES (1) ES2301195T3 (de)
WO (1) WO1998046761A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101367869B (zh) * 2000-09-30 2012-12-05 北京万泰生物药业股份有限公司 用于预防、诊断及治疗戊型肝炎病毒的多肽,及它们作为诊断试剂和疫苗
US7005130B2 (en) * 2001-01-05 2006-02-28 Virginia Tech Intellectual Properties, Inc. Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E
US20040234542A1 (en) * 2001-05-07 2004-11-25 Xiang-Jin Meng Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications
AU2003245465A1 (en) * 2002-02-13 2003-09-04 Medimolecular Pty. Ltd. Method of isolating nucleic acids from stool samples
US20090305294A1 (en) * 2003-02-13 2009-12-10 Medimolecular Pty Ltd Method of isolating nucleic acids from stool samples
EP4299767A3 (de) 2013-08-14 2024-03-27 Gen-Probe Incorporated Zusammensetzungen und verfahren zur detektion von hev-nukleinsäure
JP7777906B2 (ja) * 2022-03-01 2025-12-01 関西ペイント株式会社 木材用水性塗料組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (de) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimäre Rezeptoren durch Verbindung und Expression von DNS
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US6214970B1 (en) * 1988-06-17 2001-04-10 Genelabs Technologies, Inc. Hepatitis E virus antigens and uses therefor
US5885768A (en) * 1988-06-17 1999-03-23 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis E virus peptide antigen and antibodies
US6455492B1 (en) * 1988-06-17 2002-09-24 Genelabs Technologies, Inc. Hepatitis E virus vaccine and method
US5686239A (en) * 1988-06-17 1997-11-11 Genelabs Technologies, Inc. Hepatitis E virus peptides and methods
US5741490A (en) * 1988-06-17 1998-04-21 Genelabs Technologies, Inc. Hepatitis E virus vaccine and method
AU4058489A (en) 1988-08-08 1990-03-05 Michael A. Iffiu Collapsible recumbent bicycle with streamlined three-part folding canopy
CA2016841C (en) 1989-05-16 1999-09-21 William D. Huse A method for producing polymers having a preselected activity
CA2057052C (en) * 1990-04-05 2009-06-30 Gregory R. Reyes Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof
WO1996010580A2 (en) * 1994-10-03 1996-04-11 The Government Of The United States Of America, Re Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
CA2144855C (en) * 1992-09-18 2008-09-09 Sergei A. Tsarev Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
DE69435059D1 (de) * 1993-09-24 2008-02-14 Macfarlane Burnet Inst For Med Immunoreaktive antigene des hepatitis e viruses
EP0736087A1 (de) * 1993-12-22 1996-10-09 Abbott Laboratories Monoklonale antikoerper gegen hev orf-2 und verfahren zur deren verwendung

Also Published As

Publication number Publication date
EP1958958B1 (de) 2011-10-26
DE69839242T2 (de) 2009-03-12
EP0972048A1 (de) 2000-01-19
JP4390293B2 (ja) 2009-12-24
ATE530563T1 (de) 2011-11-15
EP1958958A1 (de) 2008-08-20
EP0972048B1 (de) 2008-03-12
CN1260000A (zh) 2000-07-12
CA2286399A1 (en) 1998-10-22
DE69839242D1 (de) 2008-04-24
JP2001524821A (ja) 2001-12-04
CN1202252C (zh) 2005-05-18
CA2286399C (en) 2009-06-30
AU739915B2 (en) 2001-10-25
AU7247098A (en) 1998-11-11
ES2301195T3 (es) 2008-06-16
WO1998046761A1 (en) 1998-10-22
US6054567A (en) 2000-04-25

Similar Documents

Publication Publication Date Title
ATE449178T1 (de) Rekombinante proteine eines pakistani stammes von hepatitis e-virus sowie ihre verwendung in diagnostischen verfahren und als vakzine
ATE218617T1 (de) Sequenzen von hepatitis-c-virus genotype 7, und deren verwendung als vorbeugende, therapeutische und diagnostische mittel
LU91396I2 (fr) "La combinaison de la protéine L1 recombinante du papillomavirus humain de types 6,11,16 et 18" -Gardasil/Silgard
ES2111524T3 (es) Peptidos de eritropoyetina (epo) y anticuerpos dirigidos contra ellos.
BR9906927A (pt) Proteìnas de neisseria meningitidis
ATE206434T1 (de) Seroreaktive bereiche auf den hpv 16 proteinen e1 und e2
PT1542732E (pt) Proteínas de fusão de mycobacterium tuberculosis
DE69632625D1 (de) Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose
DE69419966D1 (de) Impstoff gegen Streptococcus suis-Infektion
EP0593290A3 (de) Kernantigenprotein des Hepatitis C-Virus, sowie diagnostisches Verfahren und Satz von Reagenzen.
ATE389021T1 (de) Rrekombinante proteine eines pakistani-stammes von hepatitis-e-virus, ihre verwendung in diagnotischen verfahren und als impfstoff
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
NL300336I2 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
NO971529L (no) Rekombinante proteiner av en Pakistani stamme av hepatitt E og deres anvendelse i diagnostiske metoder og vaksiner
PT1035133E (pt) Proteinas de fusao compreendendo veiculos que podem induzir uma dupla resposta imune
SE9201281D0 (sv) New human monoclonal antibodies, and a method for preparation thereof
ATE248188T1 (de) Monoklonale antikörper gegen das epitop ypydvpdya,verfahren zu deren herstellung und ihre verwendung
OA09653A (en) Rubella peptides
CA2080213A1 (en) Diagnostic reagent for hepatitis c
ATE128733T1 (de) Monoklonale antikörper gegen hiv gp120.
ATE108832T1 (de) Verwendung von monoklonalen antikörpern gegen b2- mikroglobulin.
IT1284630B1 (it) Epitopi specifici di virus associati a epatiti non"a"-non"e", composizioni e metodo per rivelare anticorpi di detti epitopi.
MX9709851A (es) Epitopes neutralizadores conformacionales del virus de la anemia de pollo.
DE69331796D1 (de) Kernantigenprotein des Hepatitis C-Virus, sowie diagnostisches Verfahren und Satz von Reagenzen
DE69403211D1 (de) Immunoelektroforeseverfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties